Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-3-12
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1476-5551
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
628-31
pubmed:dateRevised
2008-5-30
pubmed:meshHeading
pubmed-meshheading:17728786-Antineoplastic Agents, pubmed-meshheading:17728786-Boronic Acids, pubmed-meshheading:17728786-Cell Line, Tumor, pubmed-meshheading:17728786-Down-Regulation, pubmed-meshheading:17728786-Drug Screening Assays, Antitumor, pubmed-meshheading:17728786-Drug Synergism, pubmed-meshheading:17728786-Enzyme Inhibitors, pubmed-meshheading:17728786-Gene Expression Regulation, Leukemic, pubmed-meshheading:17728786-Genes, Wilms Tumor, pubmed-meshheading:17728786-Humans, pubmed-meshheading:17728786-Hydroxamic Acids, pubmed-meshheading:17728786-Leukemia, Megakaryoblastic, Acute, pubmed-meshheading:17728786-Leukemia, Myelomonocytic, Chronic, pubmed-meshheading:17728786-Megakaryocytes, pubmed-meshheading:17728786-Neoplasm Proteins, pubmed-meshheading:17728786-Pyrazines, pubmed-meshheading:17728786-WT1 Proteins
pubmed:year
2008
pubmed:articleTitle
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines.
pubmed:publicationType
Letter